(^DJI) advanced for a seventh session in eight, and are now up 6.5% on the month. Pfizer
(PFE) bested all blue chips, jumping 3.20% to finish at levels last seen in 2004, propelled by a 13% increase in sales of its pain product Lyrica. Bill Clinton of course famously felt your pain, and will be pleased to know that Viagra (introduced in the same spring of 1998 that the president’s libido got him in to so much trouble; coincidence?) also posted impressive results for the pharmaceutical giant.
Buffalo Wild Wings
(BWLD) fell 1.67% yesterday and is the subject of an iffy analyst assessment this morning, but all those chickens didn’t die in vain ahead of Sunday’s Super Bowl. For Tyson Foods
(TSN), America’s largest poultry processor, rose 1.03% to a new high after getting an unusual 180 degree upgrade
Last night of all nights public television aired a fascinating documentary on Henry Ford
(F), an infamous isolationist who warned against messy foreign entanglements. Ain’t that the truth; his car company cratered 4.64% during the day after saying it expects to lose $2 billion over in Europe this year. And British bookie William Hill
(PINK:WIMHY) gained 2.1% to hit its highest level in over half a decade. Apparently the company made money hand over fist enticing customers with 100-1 bets on Big Foot appearing before December 31
. Still, maybe it isn’t too late
Today the Federal Open Market Committee concludes its two-day policy meeting, and an interest rate announcement is expected at 2:15 p.m. Eastern. It’s Hump Day of peak week for earnings reports, with Boeing
(COP), Electronic Arts
(PINK:FIATY), Hennes & Mauritz
(PINK:NTDOY), Northrop Grumman
(NOC), Phillips 66
(QCOM), and Roche Holding
(PINK:RHHBY) all due to release results.
(ALGN): The teeth-straightening company, which counts Justin Bieber among its customers, is up before the bell after being begun with a Buy at Janney Montgomery Scott.
(ACRX): Noting that FDA (Food and Drug Administration) approval of a key product may come in 2014, Mizuho starts Buy rated research and sets a $13 price target.
Buffalo Wild Wings
(NASDAQ:BWLD) Shares, down 1.67% yesterday, are assigned only a Neutral at Goldman Sachs this morning. The price objective is $82. (See also: Poultry Industry Battles Wing Price Volatility as Super Bowl Nears
(DSW): The Designer Shoe Warehouse is initiated at Telsey Advisory Group, which does not offer official research recommendations but nonetheless appears impressed with a compelling business model and improved merchandise assortments. Its price target is $78.
(LBTYA): Evercore launches Overweight rated research on LBTYA.
(PCLN): Ascendiant Capital establishes Buy rated coverage with a $870 target price. Catalysts include impressive growth prospects in international markets and considerable momentum from its Booking.com business.
(WWAV): Shares are picked up at an Outperform with Wells Fargo.
(WDAY): The stock is a new Market Perform at Northland Capital.
(See also: Stock Upgrades: Cisco Back In Business
and Stock Downgrades: Analyst Has Reservations About OpenTable.
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.